Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
To access this article, please choose from the options below
PII: S0959-8049(05)00874-9
doi:10.1016/j.ejca.2005.08.032
© 2005 Elsevier Ltd. All rights reserved.
